We provide you with 20 years of free, institutional-grade data for RGNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RGNX. Explore the full financial landscape of RGNX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1590877 | RGNX | 10-Q | Url |
| 2025-05-12 | 1590877 | RGNX | 10-Q | Url |
| 2025-03-13 | 1590877 | RGNX | 10-K | Url |
| 2024-11-06 | 1590877 | RGNX | 10-Q | Url |
| 2024-08-01 | 1590877 | RGNX | 10-Q | Url |
| 2024-05-08 | 1590877 | RGNX | 10-Q | Url |
| 2024-02-27 | 1590877 | RGNX | 10-K | Url |
| 2023-11-08 | 1590877 | RGNX | 10-Q | Url |
| 2023-08-02 | 1590877 | RGNX | 10-Q | Url |
| 2023-05-03 | 1590877 | RGNX | 10-Q | Url |
| 2023-02-28 | 1590877 | RGNX | 10-K | Url |
| 2022-11-03 | 1590877 | RGNX | 10-Q | Url |
| 2022-08-03 | 1590877 | RGNX | 10-Q | Url |
| 2022-05-04 | 1590877 | RGNX | 10-Q | Url |
| 2022-03-01 | 1590877 | RGNX | 10-K | Url |
| 2021-11-02 | 1590877 | RGNX | 10-Q | Url |
| 2021-08-09 | 1590877 | RGNX | 10-Q | Url |
| 2021-05-05 | 1590877 | RGNX | 10-Q | Url |
| 2021-03-01 | 1590877 | RGNX | 10-K | Url |
| 2020-11-04 | 1590877 | RGNX | 10-Q | Url |
| 2020-08-06 | 1590877 | RGNX | 10-Q | Url |
| 2020-05-07 | 1590877 | RGNX | 10-Q | Url |
| 2020-02-26 | 1590877 | RGNX | 10-K | Url |
| 2019-11-05 | 1590877 | RGNX | 10-Q | Url |
| 2019-08-07 | 1590877 | RGNX | 10-Q | Url |
| 2019-05-07 | 1590877 | RGNX | 10-Q | Url |
| 2019-02-27 | 1590877 | RGNX | 10-K | Url |
| 2018-11-07 | 1590877 | RGNX | 10-Q | Url |
| 2018-08-08 | 1590877 | RGNX | 10-Q | Url |
| 2018-05-08 | 1590877 | RGNX | 10-Q | Url |
| 2018-03-06 | 1590877 | RGNX | 10-K | Url |
| 2017-11-08 | 1590877 | RGNX | 10-Q | Url |
| 2017-08-08 | 1590877 | RGNX | 10-Q | Url |
| 2017-05-09 | 1590877 | RGNX | 10-Q | Url |
| 2017-03-07 | 1590877 | RGNX | 10-K | Url |
| 2016-11-09 | 1590877 | RGNX | 10-Q | Url |
| 2016-08-09 | 1590877 | RGNX | 10-Q | Url |
| 2016-05-05 | 1590877 | RGNX | 10-Q | Url |
| 2016-03-03 | 1590877 | RGNX | 10-K | Url |
| 2015-11-05 | 1590877 | RGNX | 10-Q | Url |
| 2015-08-17 | 1590877 | RGNX | S-1 | Url |
REGENXBIO Inc(NASDAQ:RGNX) 
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates ...
Website: http://www.regenxbio.com
Founded: 2008
Full Time Employees: 257
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about RGNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.